Renal-clearable fluorescent probe for early detection of pancreatic cancer in living murine models
Science Advances · 2026
DOI: 10.1126/sciadv.aei0638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Minrong Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals and Ministry of Education Key Laboratory for the Synthesis and Applica…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Fluorescent Dyes, Early Detection of Cancer, Kidney. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Open Project Program of Wuhan National Laboratory for Optoelectronics, Open Funding Project of Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals.
Abstract (Originalsprache)
Pancreatic cancer (PC) is a highly aggressive and lethal malignancy with extremely poor patient survival rates. The lack of biomarkers and deep tissue detection barriers has presented long-standing and unsolved issues, severely hindering the early diagnosis of PC even in living rodent models. Here, we report a renal-clearable leucine aminopeptidase (LAP)–activatable fluorescence probe, overturning the probe’s pharmacokinetics from the liver to kidney pathway (90% of the injection dosage). This strategy reduces interference in the liver and enables LAP as a biomarker for PC detection in murine models. After in situ response with LAP in the pancreas, renal-clearable fluorogenic fragments could be efficiently excreted into the urine, thus addressing the depth barriers of PC. Our strategy has resolved the lack of biomarkers and deep tissue detection barriers in early PC detection in murine models, which would greatly expand the bioanalytical toolbox for PC identification, further enabling the efficient screening of PC drugs at the animal level and the exploration of diagnostic methods for PC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals and Ministry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Hubei University, Wuhan 430062,…
- Britton Chance Center and MOE Key Laboratory for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan 430074, P.R. China.
ORCID-Profile: Minrong Huang, Wei Chen, Erfei Wang, Feiyi Wang, Jun Ren
Förderung
- National Natural Science Foundation of China
- Open Project Program of Wuhan National Laboratory for Optoelectronics
- Open Funding Project of Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals
- Hubei Provincial Science and Technology Innovation Platform Project
Zitieren
APA
Huang, M., Zhou, Z., Zhang, T., Xia, X., Chen, W., Wang, E., Wang, F., & Ren, J. (2026). Renal-clearable fluorescent probe for early detection of pancreatic cancer in living murine models. Science Advances. https://doi.org/10.1126/sciadv.aei0638
Vancouver
Huang M, Zhou Z, Zhang T, Xia X, Chen W, Wang E, et al. Renal-clearable fluorescent probe for early detection of pancreatic cancer in living murine models. Science Advances. 2026. doi:10.1126/sciadv.aei0638
BibTeX
@article{Huang2026,
author = {Huang, Minrong and Zhou, Zhe and Zhang, Tong and Xia, Xiaofeng and Chen, Wei and Wang, Erfei and Wang, Feiyi and Ren, Jun},
title = {Renal-clearable fluorescent probe for early detection of pancreatic cancer in living murine models},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aei0638}
}
EUVIMED